Mint-Quetiapine 25 mg (Quetiapine (Quetiapine Fumarate) TABLET) 25 MG

Mint-Quetiapine 25 mg tablets are an oral medication used for managing various mental health conditions. This generic form of quetiapine fumarate is manufactured by Mint Pharmaceuticals Inc. in Canada.

Strength

25 MG

Pack Size

10/100/500

Manufacturer / TM Owner

MINT PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mint-Quetiapine 25 mg tablets are commonly used to treat symptoms associated with certain mental health conditions. This medication is often prescribed to help manage mood disorders and other related conditions. People often ask, 'What is Mint-Quetiapine used for?' and the answer typically involves its role in supporting mental health treatment plans.

Side Effects

Mint-Quetiapine 25 mg tablets may cause common effects such as drowsiness, dizziness, and dry mouth. Some users may experience weight changes or fatigue. It's important to note that individual responses can vary, and not everyone will experience these effects.

Precautions & Warnings

When handling Mint-Quetiapine 25 mg tablets, it's important to follow the guidance provided by a healthcare professional. This medication should be stored securely and out of reach of children. Always check the packaging for specific storage instructions.

Avoid Interactions

Mint-Quetiapine 25 mg tablets may interact with certain substances, including alcohol and other medications. It's advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Some medications, particularly those that affect the central nervous system, may require careful monitoring when used with Mint-Quetiapine.

Frequently Asked Questions

Mint-Quetiapine 25 mg tablets are used to manage symptoms associated with certain mental health conditions, often as part of a treatment plan.

Store Mint-Quetiapine 25 mg tablets in a cool, dry place, away from direct sunlight and out of reach of children.

Common effects may include drowsiness, dizziness, and dry mouth, though individual experiences can vary.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Mint-Quetiapine is available in various strengths, and the appropriate dosage should be determined by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.